Evidence map›Paper›PMID 37820013›Full record

ArticleActa crystallographica Section B, Structural science, crystal engineering and materials2023

Hydrogen bonding patterns and C-H...π interactions in the structure of the antiparkinsonian drug (R)-rasagiline mesylate determined using laboratory and synchrotron X-ray powder diffraction data.

Analio J Dugarte-Dugarte, Robert A Toro, Jacco van de Streek, José Antonio Henao, Andrew N Fitch, Catherine Dejoie, José Miguel Delgado, Graciela Díaz de Delgado

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Acta crystallographica Section B, Structural science, crystal engineering and materials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Analio J Dugarte-DugarteLaboratorio de Cristalografía-LNDRX, Departamento de Química, Facultad de Ciencias, Universidad de Los Andes, Mérida, 5101, Venezuela.
Robert A ToroGrupo de Investigación en Química Estructural (GIQUE), Escuela de Química, Facultad de Ciencias, Universidad Industrial de Santander, Bucaramanga, Colombia.
Jacco van de StreekAvant-garde Materials Simulation, Alte Str. 2, Merzhausen, D-79249, Germany.
José Antonio HenaoGrupo de Investigación en Química Estructural (GIQUE), Escuela de Química, Facultad de Ciencias, Universidad Industrial de Santander, Bucaramanga, Colombia.
Andrew N FitchEuropean Synchrotron Radiation Facility (ESRF), 71 Avenue des Martyrs, CS40220, Grenoble, Cedex 9 38043, France.
Catherine DejoieEuropean Synchrotron Radiation Facility (ESRF), 71 Avenue des Martyrs, CS40220, Grenoble, Cedex 9 38043, France.
José Miguel DelgadoLaboratorio de Cristalografía-LNDRX, Departamento de Química, Facultad de Ciencias, Universidad de Los Andes, Mérida, 5101, Venezuela.
Graciela Díaz de DelgadoLaboratorio de Cristalografía-LNDRX, Departamento de Química, Facultad de Ciencias, Universidad de Los Andes, Mérida, 5101, Venezuela.ORCID 0000-0001-5511-4230
University of the Andes · VEEuropean Synchrotron Radiation Facility · FRIndustrial University of Santander · CO

Funding

National Science Foundation ACI-1548562
6 · The paper itself

Abstract

The structure of (R)-rasagiline mesylate [(R)-RasH

Indexed as

crystal structureDFT-D calculationsHirshfeld surface analysisParkinson's diseaserasagiline mesylatestructure determinationsynchrotron radiation

Identifiers

PMID37820013
PMCPMC10833353
OpenAlexW4387517386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.